Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients

about

Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients

Item

http://www.wikidata.org/entity/Q57053840

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@en

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@nl

type

Item

label

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@en

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@nl

prefLabel

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@en

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@nl

P1476

Achievement of 2009 and 2017 K ...... 4 and 5 non-dialysis patients

@en

P2093

Bernadette Darné

http://www.w3.org/2001/XMLSchema#string

Eric Daugas

http://www.w3.org/2001/XMLSchema#string

Guillaume Jean

http://www.w3.org/2001/XMLSchema#string

Gérard M London

http://www.w3.org/2001/XMLSchema#string

Hubert Roth

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Bouchet

http://www.w3.org/2001/XMLSchema#string

Thierry Hannedouche

http://www.w3.org/2001/XMLSchema#string

Tilman B Drüeke

http://www.w3.org/2001/XMLSchema#string

P2860

Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

The Epidemiologic Transition: A Theory of the Epidemiology of Population Change

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.

Improving global outcomes in mineral and bone disorders.

Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.

CKD Prevalence Varies across the European General Population

Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.

P304

710-719

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CKJ/SFY015

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Denis Fouque

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30288267

http://www.w3.org/2001/XMLSchema#string

P921

nephrology

P932

6165763

http://www.w3.org/2001/XMLSchema#string